The Role of Depression in Retention in Care for Persons Living with HIV

AIDS Patient Care and STDs

Volumn 30, Issue 1, 2016, Pages 34-38

  Zuniga, Julie Ann ^a   Yoo Jeong, Moka ^b   Dai, Tian ^c   Guo, Ying ^c   Waldrop Valverde, Drenna ^b  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMBULATORY CARE; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CLUSTER ANALYSIS; COGNITIVE DEFECT; DEPRESSION; FACTORIAL ANALYSIS; FEMALE; HEALTH LITERACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MOOD; PATIENT CARE; PSYCHOSOMATIC DISORDER; SOCIAL DETERMINANTS OF HEALTH; UNITED STATES; COMPLICATION; FACTOR ANALYSIS; FLORIDA; HEALTH CARE SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; MEDICATION COMPLIANCE; MIDDLE AGED; PATIENT ATTITUDE; PREVALENCE; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DEPRESSION; FACTOR ANALYSIS, STATISTICAL; FEMALE; FLORIDA; HEALTH CARE SURVEYS; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES;

EID: 84954168703     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2015.0214     Document Type: Article

References (32)

1. Davidson KW, Rieckmann N, Rapp MA. Definitions and distinctions among depressive syndromes and symptoms: Implications for a better understanding of the depressioncardiovascular disease association. Psychosom Med 2005; 67:S6-S9.
2. Do AN, Rosenberg ES, Sullivan PS, et al. Excess burden of depression among HIV-infected persons receiving medical care in the United States: Data from the medical monitoring project and the behavioral risk factor surveillance system. PloS One 2014;9:e92842.
3. Asch SM, Kilbourne AM, Gifford AL, et al. Underdiagnosis of depression in HIV: Who are we missing J Gen Intern Med 2003;18:450-460.
4. Starace F, Ammassari A, Trotta MP, et al. Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002;31: S136-S139.
5. Simoni JM, Safren SA, Manhart LE, et al. Challenges in addressing depression in HIV research: Assessment, cultural context, and methods. AIDS Behav 2011;15:376-388.
6. Gordon LL, Gharibian D, Chong K, Chun H. Comparison of HIV virologic failure rates between patients with variable adherence to three antiretroviral regimen types. AIDS Patient Care STDs 2015;29:384-388.
7. Martin M, Del Cacho E, Codina C, et al. Relationship between adherence level, type of the antiretroviral regimen, and plasma HIV type 1 RNA viral load: A prospective cohort study. AIDS Res Human Retroviruses 2008;24: 1263-1268.
8. Bangsberg DR. Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis 2006;43:939-941.
9. Haynes RB. Introduction. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore, MD: Johns Hopkins Press; 1979, pp. 1-7.
10. Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis 2011;52:793-800.
11. Centers for Disease Control and Prevention. HIV/AIDS: Recommended prevention services. Updated April 15, 2013. Available at: http://www.cdc.gov/hiv/prevention/programs/pwp/linkage.html (Last accessed February 2, 2015).
12. Giordano TP, Gifford AL, White AC, et al. Retention in care: A challenge to survival with HIV infection. Clin Infect Dis 2007;44:1493-1499.
13. Torian LV, Xia Q, Wiewel EW. Retention in care and viral suppression among persons living with HIV/AIDS in New York City, 2006-2010. Am J Public Health 2014;104:e24-e29.
14. Krumme AA, Kaigamba F, Binagwaho A, Murray MB, Rich ML, Franke MF. Depression, adherence and attrition from care in HIV-infected adults receiving antiretroviral therapy. J Epidemiol Commun Health 2015;69:284-289.
15. Holzemer WL, Corless IB, Nokes KM, et al. Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care STDS 1999;13:185-197.
16. Smith LR, Fisher JD, Cunningham CO, Amico KR. Understanding the behavioral determinants of retention in HIV care: A qualitative evaluation of a situated information, motivation, behavioral skills model of care initiation and maintenance. AIDS Patient Care STDs 2012;26:344-355.
17. Pecoraro A, Royer-Malvestuto C, Rosenwasser B, et al. Factors contributing to dropping out from and returning to HIV treatment in an inner city primary care HIV clinic in the United States. AIDS Care 2013;25:1399-1406.
18. Bhatia R, Hartman C, Kallen MA, Graham J, Giordano TP. Persons newly diagnosed with HIV infection are at high risk for depression and poor linkage to care: results from the Steps Study. AIDS Behav 2011;15:1161-1170.
19. Magnus M, Jones K, Phillips G 2nd, et al. Characteristics associated with retention among African American and Latino adolescent HIV-positive men: Results from the outreach, care, and prevention to engage HIV-seropositive young MSM of color special project of national significance initiative. J Acquir Immune Defic Syndr 2010;53: 529-536.
20. Blank AE, Fletcher J, Verdecias N, et al. Factors associated with retention and viral suppression among a cohort of HIV+ women of color. AIDS Patient Care STDs 2015;29: S27-S35.
21. Buchberg MK, Fleetcher FE, Vidrine DJ, et al. A mixedmethods approach to understanding barriers to postpartum retention in care among low-income, HIV-infected women. AIDS Patient Care STDs 2015;29:126-132.
22. Waldrop-Valverde D, Guo Y, Ownby R, Rodriguez A, Jones D. Risk and protective factors for retention in HIV care. AIDS Behav 2014;18:1483-1491.
23. Mugavero MJ, Davila JA, Nevin CR, Giordano TP. From access to engagement: Measuring retention in outpatient HIV clinical care. AIDS Patient Care STDs 2010;24:607-613.
24. Cureton EE, Mulaik SA. The weighted varimax rotation and the promax rotation. Psychometrika 1975;40:183-195.
25. Carlson M, Wilcox R, Chou CP, et al. Psychometric properties of reverse-scored items on the CES-D in a sample of ethnically diverse older adults. Psychol Assess 2011;23:558-562.
26. Zhang W, O'Brien N, Forrest JI, et al. Validating a shortened depression scale (10 item CES-D) among HIVpositive people in British Columbia, Canada. PLoS One 2012;7:e40793.
27. Low-Beer S, Chan K, Yip B, et al. Depressive symptoms decline among persons on HIV protease inhibitors. J Acquir Immune Def Syndr 2000;23:295-301.
28. Turvey CL, Wallace RB, Herzog R. A revised CES-D measure of depressive symptoms and a DSM-based measure of major depressive episodes in the elderly. Intl Psychogeriatr 1999;11:139-148.
29. Golub ET, Latka M, Hagen H, et al. Screening for depressive symptoms among HCV-infected injection drug users: Examination of the utility of the CES-D and the Beck Depression Inventory. J Urban Health 2004;81:278-290.
30. Carlson M, Wilcox R, Clou CP, et al. Psychometric properties of reverse-scored items on the CES-D in a sample of ethnically diverse older adults. Psychol Assess 2011;23: 558-562.
31. Cook JA, Cohen MH, Burke J, et al. Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women. J Acquir Immune Def Syndr 2002;30:401-409.
32. Du Bois SN, McKirnan DJ. A longitudinal analysis of HIV treatment adherence among men who have sex with men: A cognitive escape perspective. AIDS Care 2012;24:1425-1431.